This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Simon Crawford Bristow: Innovator in Pharmaceutical Processes
Introduction
Simon Crawford Bristow is a notable inventor based in West Yorkshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of aripiprazole particles. His innovative methods have the potential to enhance the efficiency of drug formulation processes.
Latest Patents
Simon holds a patent for a process of making aripiprazole particles. This method involves the preparation of crystalline aripiprazole monohydrate through a technique known as solution enhanced dispersion by supercritical fluid. In this process, water is introduced to a stream of supercritical fluid, which then mixes with a solution containing aripiprazole and a solvent. The result is the simultaneous dispersion and extraction of aripiprazole from the mixture by the supercritical fluid. He has 1 patent to his name.
Career Highlights
Simon is associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work there focuses on advancing drug development and improving pharmaceutical formulations. His expertise in innovative processes has contributed to the company's mission of discovering and delivering innovative medicines.
Collaborations
Throughout his career, Simon has collaborated with esteemed colleagues, including David R Worthen and Philip Michael Cocks. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Simon Crawford Bristow is a distinguished inventor whose work in pharmaceutical processes exemplifies innovation in drug formulation. His contributions continue to impact the field positively, paving the way for advancements in medication development.